Functional Cooperation between Interleukin-17 and Tumor Necrosis Factor-α Is Mediated by CCAAT/Enhancer-binding Protein Family Members
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Interleukin (IL)-17 is a recently described cytokine involved in the amplification of inflammatory responses and pathologies. A hallmark feature of IL-17 is its ability to induce expression of other cytokines and chemokines. In addition, IL-17 potently synergizes with tumor necrosis factor-alpha (TNFalpha) to up-regulate expression of many target genes, particularly IL-6. Despite the many observations of IL-17 signaling synergy observed to date, little is known about the molecular mechanisms that underlie this phenomenon. In the osteoblastic cell line MC-3T3, we have found that IL-17 and TNFalpha exhibit potent synergy in mediating IL-6 secretion. Here, we show that at least part of the functional cooperation between IL-17 and TNFalpha occurs at the level of IL-6 gene transcription. Both the NF-kappaB and CCAAT/enhancer-binding protein (C/EBP; NF-IL6) sites in the IL-6 promoter are important for cooperative gene expression, but NF-kappaB does not appear to be the direct target of the combined signal. Microarray analysis using the Affymetrix mouse MG-U74v2 chip identified C/EBPdelta as another gene target of combined IL-17- and TNFalpha-induced signaling. Because C/EBP family members are known to control IL-6, we examined whether enhanced C/EBPdelta expression is involved in the cooperative up-regulation of IL-6 by IL-17 and TNFalpha. Accordingly, we show that C/EBPdelta (or the related transcription factor C/EBPbeta) is essential for expression of IL-6. Moreover, overexpression of C/EBPdelta (and, to a lesser extent, C/EBPbeta) could substitute for the IL-17 signal at the level of IL-6 transcription. Thus, C/EBP family members, particularly C/EBPdelta, appear to be important for the functional cooperation between IL-17 and TNFalpha.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“NF-κB subsequently upregulates expression of IκBζ and Bcl3, noncanonical members of the NF-κB family that in turn promote expression of various IL-17-NF-κB driven pro-inflammatory and anti-microbial genes”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Ruddy et al., 2004
In the citing paper
“In addition to synergizing with strong NF-κB activators such as TNFα, lipopolysaccharide (LPS), IL-1β and lymphotoxin, IL-17 cooperates with IFNγ (activator of STAT1), IL-13 (STAT6), TGFβ (SMADs), fibroblast growth factor (FGF)2 (Ras:Raf) and a Candida albicans-derived pore-forming toxin from Candida albicans (c-Fos)”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Ruddy et al., 2004
In the citing paper
“One of the best-studied examples of synergy is with TNFα”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Ruddy et al., 2004
In the citing paper
“One curious aspect of IL-17 biology is that this cytokine is consistently a modest activator of signaling in vitro, regardless of the cell system analyzed”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Ruddy et al., 2004
Citations
Cites
Tumor necrosis factor signaling
Wajant, H., Pfizenmaier, K., & Scheurich, P. (2003) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401189 · Cited by 2,359
Aggarwal, S., Ghilardi, N., Xie, M.-H., de Sauvage, F. J., & Gurney, A. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207577200 · Cited by 1,847
Kotake, S., Udagawa, N., Takahashi, N., Matsuzaki, K., Itoh, K., Ishiyama, S., Saito, S., Inoue, K., Kamatani, N., Gillespie, M. T., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5703 · Cited by 1,696
T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines
Fossiez, F., Djossou, O., Chomarat, P., Flores-Romo, L., Ait-Yahia, S., Maat, C., Pin, J. J., Garrone, P., Garcia, E., Saeland, S., et al. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.6.2593 · Cited by 1,526
A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family.
Akira, S., Isshiki, H., Sugita, T., Tanabe, O., Kinoshita, S., Nishio, Y., Nakajima, T., Hirano, T., & Kishimoto, T. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08316.x · Cited by 1,482
gp 130 AND THE INTERLEUKIN-6 FAMILY OF CYTOKINES
Taga, T., & Kishimoto, T. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.797 · Cited by 1,461
CCAAT/enhancer-binding proteins: structure, function and regulation
RAMJI, D. P., & FOKA, P. (2002) · Biochemical Journal · doi:10.1042/bj20020508 · Cited by 1,400
Andersson, S., Davis, D. L., Dahlbäck, H., Jörnvall, H., & Russell, D. W. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83172-6 · Cited by 1,229
Human IL-17: a novel cytokine derived from T cells
Yao, Z., Painter, S. L., Fanslow, W. C., Ulrich, D., Macduff, B. M., Spriggs, M. K., & Armitage, R. J. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.12.5483 · Cited by 1,021
Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor
Yao, Z., Fanslow, W. C., Seldin, M. F., Rousseau, A.-M., Painter, S. L., Comeau, M. R., Cohen, J. I., & Spriggs, M. K. (1995) · Immunity · doi:10.1016/1074-7613(95)90070-5 · Cited by 994
Research works printed but not linked: 2
- Libermann, 1990, Mol. Cell. Biol., 10, 2327
- Andoh, 2002, Int. J. Mol. Med., 10, 631
Cited by
Items 101–200 of 365
Cytokines in inflammatory bowel disease
Moldoveanu, A. C., Diculescu, M., & Fierbinteanu-Braticevici, C. G. (2015) · Romanian Journal of Internal Medicine · doi:10.1515/rjim-2015-0016 · Cited by 113
“IL-17 favorizes the production of multiple pro-inflammatory factors, including TNF-α, IL-6 and IL-1β, which has led to the conclusion that IL-17 has a very important role in the amplification and localization of inflammation [45-47], as well as the process of fibrosis in CD [48][49].”
The metabolism-modulating activity of IL-17 signaling in health and disease
Bechara, R., McGeachy, M. J., & Gaffen, S. L. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20202191 · Cited by 104
Self-citationTh17 and Treg lymphocytes in obesity and Type 2 diabetic patients
Wang, M., Chen, F., Wang, J., Zeng, Z., Yang, Q., & Shao, S. (2018) · Clinical Immunology · doi:10.1016/j.clim.2018.09.005 · Cited by 111
IL-17 and IL-17-producing cells and liver diseases, with focus on autoimmune liver diseases
Beringer, A., & Miossec, P. (2018) · Autoimmunity Reviews · doi:10.1016/j.autrev.2018.06.008 · Cited by 108
Th 17 cells interplay with Foxp3+ Tregs in regulation of inflammation and autoimmunity
Mai, J. (2010) · Frontiers in Bioscience · doi:10.2741/3657 · Cited by 93
“IL-17 has been shown, in gel shift analyses, to activate NF-kappaB via p50 and p65, which are the key components of the canonical NF-kappaB pathway (127).”
BackgroundA tale of two cytokines: IL-17 and IL-22 in asthma and infection
Manni, M. L., Robinson, K. M., & Alcorn, J. F. (2013) · Expert Review of Respiratory Medicine · doi:10.1586/17476348.2014.854167 · Cited by 102
Du, W.-J., Zhen, J.-H., Zeng, Z.-Q., Zheng, Z.-M., Xu, Y., Qin, L.-Y., & Chen, S.-J. (2013) · Diagnostic Pathology · doi:10.1186/1746-1596-8-40 · Cited by 93
“TGF-β together with IL-6 can mediate the de novo differentiation of IL-17-producing T cells from naive CD4+ Tcell precursors [8].”
BackgroundInfluentialIsolation of seven IL-17 family genes from the Japanese pufferfish Takifugu rubripes
Korenaga, H., Kono, T., & Sakai, M. (2010) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2010.01.016 · Cited by 91
IL-17C/IL-17RE: Emergence of a Unique Axis in TH17 Biology
Nies, J. F., & Panzer, U. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00341 · Cited by 104
“Pathways activated by IL17 receptor signaling include nuclear factor kappa-light-chainenhancer of activated B cells (NF-κB) (58), inhibitor of NF-κB ζ (IκBζ) (59), mitogen-activated protein kinase (MAPK) (60– 62), and CCAAT/enhancer-binding protein (C/EBP) (63, 64).”
BackgroundSlowikowski, K., Nguyen, H. N., Noss, E. H., Simmons, D. P., Mizoguchi, F., Watts, G. F. M., Gurish, M. F., Brenner, M. B., & Raychaudhuri, S. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1912702117 · Cited by 89
“Two TFs, NF-κB and C/EBP, control synergistic production of IL-6 (11, 15) in response to the combination of TNF and IL-17A.”
BackgroundAdaptive T cell immune responses and atherogenesis
Taleb, S., Tedgui, A., & Mallat, Z. (2010) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2010.02.003 · Cited by 92
“IL-17 activates NF-kB, a hallmark transcription factor associated with the induction of factors including IL-1, IL-6, TNF-a, NOS-2, metalloproteases, and chemokines, resulting in the induction of inflammation [42].”
BackgroundYou, T., Bi, Y., li, J., Zhang, M., Chen, X., Zhang, K., & Li, J. (2017) · Scientific Reports · doi:10.1038/srep41779 · Cited by 102
TH17 cells in asthma and inflammation
Aujla, S. J., & Alcorn, J. F. (2011) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.02.002 · Cited by 104
Bechara, R., Amatya, N., Bailey, R. D., Li, Y., Aggor, F. E. Y., Li, D.-D., Jawale, C. V., Coleman, B. M., Dai, N., Gokhale, N. S., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.abd1287 · Cited by 89
“We originally linked C/EBP and C/EBP to IL-17 signaling in 2004, finding that C/EBP, in particular, contributes to IL-17 activation of downstream genes and to signaling cooperativity between IL-17 and TNF (7).”
BackgroundMethodInfluentialSelf-citationDainichi, T., Matsumoto, R., Mostafa, A., & Kabashima, K. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01107 · Cited by 96
IL-17 Signaling for mRNA Stabilization Does Not Require TNF Receptor-Associated Factor 6
Hartupee, J., Liu, C., Novotny, M., Sun, D., Li, X., & Hamilton, T. A. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.3.1660 · Cited by 88
“IL-6 is known to be unstable and sensitive to mRNA stabilization (16), but the IL-17 response may also use an indirect transcriptional mechanism via the induction of C/EBP and C/EBP (46, 47).”
A bone-protective role for IL-17 receptor signaling in ovariectomy-induced bone loss
Goswami, J., Hernández‐Santos, N., Zuniga, L. A., & Gaffen, S. L. (2009) · European Journal of Immunology · doi:10.1002/eji.200939670 · Cited by 87
“IL-17A has been shown to increase RANKL expression and other inflammatory effectors in OBs, further stimulating bone turnover [8,36].”
BackgroundSelf-citationIL-17 inhibits adipogenesis in part via C/EBPα, PPARγ and Krüppel-like factors
Ahmed, M., & Gaffen, S. L. (2013) · Cytokine · doi:10.1016/j.cyto.2012.12.007 · Cited by 86
“Expression of both C/EBPb and C/EBPd is positively regulated by IL-17 in several mesenchymal cell types [26,27].”
BackgroundResultSelf-citationYu, J. J., Ruddy, M. J., Conti, H. R., Boonanantanasarn, K., & Gaffen, S. L. (2008) · Infection and Immunity · doi:10.1128/iai.01209-07 · Cited by 85
“In the context of experimental PD, the infected IL-17RAKO mice showed only slightly decreased production of IL-6, which was not statistically different from that for WT mice (Fig.”
BackgroundSelf-citationKeratinocytes contribute intrinsically to psoriasis upon loss of Tnip1 function
Ippagunta, S. K., Gangwar, R., Finkelstein, D., Vogel, P., Pelletier, S., Gingras, S., Redecke, V., & Häcker, H. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1606996113 · Cited by 85
“The latter observation is particularly interesting in the context of IL-17– induced gene regulation, given that C/EBP family members appear to be important regulators of IL-17–mediated gene activation (52, 53).”
BackgroundBougarn, S., Cunha, P., Gilbert, F. B., Harmache, A., Foucras, G., & Rainard, P. (2011) · Cytokine · doi:10.1016/j.cyto.2011.09.020 · Cited by 88
Friedrich, M., Diegelmann, J., Schauber, J., Auernhammer, C. J., & Brand, S. (2014) · Mucosal Immunology · doi:10.1038/mi.2014.124 · Cited by 91
“This functional redundancy is consistent with previous reports.(52) In summary, these experiments show that the synergistic IL-17C production by IL-17A and TNF-a in human IECs is dependent on C/EBPb- and C/EBPd-regulated transcription and not mRNA stabilization, as previously observed for other IL-17A-induced cytokine…”
ResultClinical and Immunological Responses in Ocular Demodecosis
Kim, J. H., Chun, Y. S., & Kim, J. (2011) · Journal of Korean Medical Science · doi:10.3346/jkms.2011.26.9.1231 · Cited by 83
“Synergy with other inflammatory cytokines such as IL-1β, tumor necrosis factor (TNF)-α, and IFN-γ leads to up-regulation of gene expression and progression and amplification of local inflammation (23, 24).”
BackgroundIL-17 suppresses TNF-α–induced CCL27 production through induction of COX-2 in human keratinocytes
Kanda, N., Koike, S., & Watanabe, S. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.08.014 · Cited by 82
IRF4 and its regulators: evolving insights into the pathogenesis of inflammatory arthritis?
Biswas, P. S., Bhagat, G., & Pernis, A. B. (2010) · Immunological Reviews · doi:10.1111/j.0105-2896.2009.00864.x · Cited by 81
“of the signal transduction cascade activated by IL-17RA engagement (21, 22).”
BackgroundTh17 Cells in Periodontitis and Its Regulation by A20
Huang, N., Dong, H., Luo, Y., & Shao, B. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.742925 · Cited by 100
“C/EBP b not only mediates and enhances the synergistic effect of IL-17 and TNF signal, but also upregulates the expression of inflammatory mediators such as IL-6 (94, 95).”
BackgroundAmatya, N., Childs, E. E., Cruz, J. A., Aggor, F. E. Y., Garg, A. V., Berman, A. J., Gudjonsson, J. E., Atasoy, U., & Gaffen, S. L. (2018) · Science Signaling · doi:10.1126/scisignal.aat4617 · Cited by 75
“IL-17 enhanced Cebpb and Nfkbiz mRNA, albeit modestly (7, 56), whereas concomitant protein expression of both TFs was profoundly increased.”
InfluentialSelf-citationExpression of IL-33 in the epidermis: The mechanism of induction by IL-17
Meephansan, J., Komine, M., Tsuda, H., Karakawa, M., Tominaga, S., & Ohtsuki, M. (2013) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2013.04.014 · Cited by 85
Wittchen, F., Suckau, L., Witt, H., Skurk, C., Laßner, D., Fechner, H., Sipo, I., Ungethüm, U., Ruíz, P., Pauschinger, M., et al. (2006) · Journal of Molecular Medicine · doi:10.1007/s00109-006-0122-9 · Cited by 76
Role of the JAK-STAT Pathway in Bovine Mastitis and Milk Production
Khan, M. Z., Khan, A. A., Xiao, J., Ma, Y., Ma, J., Gao, J., & Cao, Z. (2020) · Animals · doi:10.3390/ani10112107 · Cited by 86
“Moreover, IL-17 also activates IL-6 with IFN-γ and tumor necrosis factor-alpha (TNF-α) [100].”
BackgroundInterleukin-10 improves stroke outcome by controlling the detrimental Interleukin-17A response
Piepke, M., Clausen, B. H., Ludewig, P., Vienhues, J. H., Bedke, T., Javidi, E., Rissiek, B., Jank, L., Brockmann, L., Sandrock, I., et al. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02316-7 · Cited by 78
“Outcomes of the IL-17A receptor activation depend on the cooperative stimulation by other cytokines, such as IL-1β and TNF-α [35], which are upregulated in the ischemic brain tissue and can lead to synergistic activation of downstream signaling pathways [22].”
BackgroundNovel Immune Mechanisms in Hypertension and Cardiovascular Risk
Nosalski, R., McGinnigle, E., Siedliński, M., & Guzik, T. J. (2017) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-017-0537-6 · Cited by 79
Crucial roles of binding sites for NF-κB and C/EBPs in IκB-ζ-mediated transcriptional activation
Matsuo, S., Yamazaki, S., Takeshige, K., & Muta, T. (2007) · Biochemical Journal · doi:10.1042/bj20061797 · Cited by 70
Act1 modulates autoimmunity through its dual functions in CD40L/BAFF and IL-17 signaling.
Li, X.-X. (2008) · Cytokine · doi:10.1016/j.cyto.2007.09.015 · Cited by 78
Beringer, A., Thiam, N. N., Molle, J., Bartosch, B., & Miossec, P. (2018) · Clinical & Experimental Immunology · doi:10.1111/cei.13140 · Cited by 82
Immunocompetent Properties of Human Osteoblasts: Interactions With T Lymphocytes
Stanley, K. T., Dort, C. J. V., Motyl, C. D., Endres, J., & Fox, D. A. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.051004 · Cited by 72
The role of IL-17 in psoriasis
Malakouti, M., Brown, G. E., Wang, E., Koo, J. Y. M., & Levin, E. C. (2014) · Journal of Dermatological Treatment · doi:10.3109/09546634.2013.879093 · Cited by 81
“Furthermore, IL-17A acts synergistically with TNF-a to augment the keratinocyte response to inflammatory cytokines (22,23).”
BackgroundXin, L., Zhang, H., Zhang, R., Li, H., Wang, W., Wang, L., Wang, H., Qiu, L., & Song, L. (2015) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2015.08.002 · Cited by 67
TLR2 Deficiency Leads to Increased Th17 Infiltrates in Experimental Brain Abscesses
Nichols, J. R., Aldrich, A. L., Mariani, M. M., Vidlak, D., Esen, N., & Kielian, T. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802656 · Cited by 67
Interleukin-27 Receptor Limits Atherosclerosis in Ldlr −/− Mice
Koltsova, E. K., Kim, G., Lloyd, K. M., Saris, C. J. M., von Vietinghoff, S., Kronenberg, M., & Ley, K. F. (2012) · Circulation Research · doi:10.1161/circresaha.112.277525 · Cited by 70
“and IL-17A can upregulate IL-6 production in osteoblasts by activating the transcription factor C/EBPδ.(47) In endothelial”
BackgroundAntibody blockade of IL-17 family cytokines in immunity to acute murine oral mucosal candidiasis
Whibley, N., Tritto, E., Traggiai, E., Kolbinger, F., Moulin, P., Brees, D., Coleman, B. M., Mamo, A. J., Garg, A. V., Jaycox, J. R., et al. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.4a0915-428r · Cited by 65
“supernatants was measured as a readout for IL-17 activity [52, 53].”
Self-citationInterleukin‐17 regulates matrix metalloproteinase activity in human pulmonary tuberculosis
Singh, S., Maniakis‐Grivas, G., Singh, U. K., Asher, R., Mauri, F. A., Elkington, P. T., & Friedland, J. S. (2017) · The Journal of Pathology · doi:10.1002/path.5013 · Cited by 66
“A biologically relevant feature of IL-17 is its strong cooperative and synergistic effect via mRNA stabilization of other inflammatory cytokines [48], which may account for its effect on MMP-3 secretion in the TB network between epithelial cells and monocytes.”
BackgroundThe potential of interleukin-17 to mediate hematopoietic response
Krstić, J., Mojsilović, S. B., Jovčić, G., & Bugarski, D. S. (2012) · Immunologic Research · doi:10.1007/s12026-012-8276-8 · Cited by 64
“IL-17 also induces many genes in stromal cells, including those implicated in hematopoiesis, such as IL-6 gene and its transcriptional regulators (C/EPB family, IjBf), different CC and CXC chemokines, and apoptosisrelated proteins, such as FAS and Lipocalin 2 [50, 51].”
BackgroundZhou, Y., Toh, M., Zrioual, S., & Miossec, P. (2007) · Cytokine · doi:10.1016/j.cyto.2007.06.002 · Cited by 70
Sparna, T., Rétey, J., Schmich, K., Albrecht, U., Naumann, K., Gretz, N., Fischer, H., Bode, J. G., & Merfort, I. (2010) · BMC Genomics · doi:10.1186/1471-2164-11-226 · Cited by 66
“Additionally, Nfkbiz and C/EBPs were proven to induce a subset of genes by cooperating with one another in HEK293 cells and osteoblasts derived cells [54,55].”
BackgroundInterleukin-17: friend or foe in atherosclerosis?
Taleb, S., Tedgui, A., & Mallat, Z. (2010) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32833dc7f9 · Cited by 63
Hydrogen sulfide alleviates hypertensive kidney dysfunction through an epigenetic mechanism
Weber, G. J., Pushpakumar, S. B., & Sen, U. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00637.2016 · Cited by 63
Targeting IL-17 in autoimmunity and inflammation
Kim, B. S., Park, Y.-J., & Chung, Y. (2016) · Archives of Pharmacal Research · doi:10.1007/s12272-016-0823-8 · Cited by 66
“Microarray analysis revealed that CCAAT/enhancer-binding protein transcription factors (C/EBPb, C/EBPd) are induced and mediate the expression of lipocalin 2 and IL-6 upon IL-17A stimulation (Ruddy et al. 2004).”
BackgroundIL-17: Balancing Protective Immunity and Pathogenesis
Sun, L., Wang, L., Moore, B. B., Zhang, S., Xiao, P., Decker, A. M., & Wang, H. (2023) · Journal of Immunology Research · doi:10.1155/2023/3360310 · Cited by 78
Saran, A., Nishizaki, D., Lippman, S. M., Kato, S., & Kurzrock, R. (2025) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2025.01.002 · Cited by 71
Orchestrated Cytokines Mediated by Biologics in Psoriasis and Its Mechanisms of Action
Noor, A. A. M., Azlan, M., & Redzwan, N. M. (2022) · Biomedicines · doi:10.3390/biomedicines10020498 · Cited by 66
SEF/IL-17R (SEFIR) Is Not Enough
Onishi, R. M., Park, S. J., Hanel, W., Ho, A. W., Maitra, A., & Gaffen, S. L. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.121418 · Cited by 56
Self-citationThe Double Game Played by Th17 Cells in Infection: Host Defense and Immunopathology
Paroli, M., Caccavale, R., Fiorillo, M. T., Spadea, L., Gumina, S., Candela, V., & Paroli, M. P. (2022) · Pathogens · doi:10.3390/pathogens11121547 · Cited by 62
Wine, E., Mack, D. R., Hyams, J. S., Otley, A. R., Markowitz, J. F., Crandall, W., LeLeiko, N. S., Muise, A. M., Griffiths, A. M., & Turner, D. (2013) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2012.12.012 · Cited by 56
Zafiriou, E., Daponte, A., Siokas, V., Tsigalou, C., Dardiotis, E., & Bogdanos, D. P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.699848 · Cited by 82
Osteoimmunology in Periodontitis: Local Proteins and Compounds to Alleviate Periodontitis
Sirisereephap, K., Maekawa, T., Tamura, H., Hiyoshi, T., Domon, H., Isono, T., Terao, Y., Maeda, T., & Tabeta, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105540 · Cited by 59
“Periodontitis-related inflammatory cytokines, such as tumor necrosis factor (TNF) and IL-1β, produced from host cells exposed to the dental biofilm, produce a synergistic effect by increasing IL-6 synthesis resulting in increased Th17 cell activation [31].”
BackgroundFocal bone involvement in inflammatory arthritis: the role of IL17
Rossini, M., Viapiana, O., Adami, S., Idolazzi, L., Fracassi, E., & Gatti, D. (2015) · Rheumatology International · doi:10.1007/s00296-015-3387-x · Cited by 59
T helper type 17 in psoriasis: From basic immunology to clinical practice
Chiu, H., Cheng, Y., & Tsai, T. (2012) · Dermatologica Sinica · doi:10.1016/j.dsi.2012.08.002 · Cited by 56
Ge, D., Dauchy, R. T., Liu, S., Zhang, Q., Mao, L., Dauchy, E. M., Blask, D. E., Hill, S. M., Rowan, B. G., Brainard, G. C., et al. (2013) · Journal of Pineal Research · doi:10.1111/jpi.12084 · Cited by 58
“Recently, it has been shown that GSK3B phosphorylates C/EBPd at threonine 156, leading to degradation of C/EBPd, thus attenuating Tolllike receptor 4-induced inflammation-associated genes in macrophages and tumor cells [45].”
BackgroundInfluentialMarzano, A. V., Cugno, M., Trevisan, V., Lazzari, R., Fanoni, D., Berti, E., & CROSTI, C. (2011) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463201102400218 · Cited by 54
“Moreover, it facilitates 'l-Iymphocyte infiltration and activation by stimulating the expression of intercellular adhesion molecule-1 (23) and amplifies the immune response by synergizing with various other cytokines, in particular with TNF-a (24), and inducing the production of matrix metalloproteinases (MMPs) (25).”
BackgroundSca‐1 + cardiac fibroblasts promote development of heart failure
Chen, G., Bracamonte‐Baran, W., Diny, N. L., Hou, X., Talor, M. V., Fu, K., Liu, Y., Davogustto, G., Vasquez, H., Taegtmeyer, H., et al. (2018) · European Journal of Immunology · doi:10.1002/eji.201847583 · Cited by 53
Ciona intestinalis interleukin 17-like genes expression is upregulated by LPS challenge
Vizzini, A., Falco, F. D., Parrinello, D., Sanfratello, M. A., Mazzarella, C., Parrinello, N., & Cammarata, M. (2014) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2014.09.014 · Cited by 57
IL-17 induces the production of IL-16 in rheumatoid arthritis
Cho, M., Jung, Y. O., Kim, K., Park, M., Oh, H.-J., Ju, J., Cho, Y. G., Min, J., Kim, S., Park, S., et al. (2008) · Experimental & Molecular Medicine · doi:10.3858/emm.2008.40.2.237 · Cited by 52
“In synergy with other proinflammatory cytokines such as IL-1β, TNF-α, and IFN-γ, IL-17 provokes local inflammation and amplification of inflammatory responses (Ruddy et al., 2004; Albanesi et al., 1999; Witowski et al., 2000).”
BackgroundInterleukin-17: Potential Target for Chronic Wounds
Hadian, Y., Bagood, M. D., Dahle, S. E., Sood, A., & Isseroff, R. R. (2019) · Mediators of Inflammation · doi:10.1155/2019/1297675 · Cited by 55
López-Pedrera, C., Aguirre, M. A., Barbarroja, N., & Cuadrado, M. J. (2010) · BioMed Research International · doi:10.1155/2010/607084 · Cited by 50
Kurschus, F. C., & Moos, S. (2017) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2017.06.010 · Cited by 60
Interleukin-17 as a key player in neuroimmunometabolism
Douglas, A., Stevens, B., & Lynch, L. (2023) · Nature Metabolism · doi:10.1038/s42255-023-00846-3 · Cited by 49
Shen, L., Zhang, H., Yan, T., Zhou, G., & Liu, R. (2015) · Gene · doi:10.1016/j.gene.2015.04.028 · Cited by 54
Zhao, Y., Cooper, D. K. C., Wang, H., Chen, P., He, C., Cai, Z., Mou, L., Luan, S., & Gao, H. (2019) · Xenotransplantation · doi:10.1111/xen.12502 · Cited by 52
Chaves, S., Perdigón, G., & de LeBlanc, A. D. M. (2011) · Journal of Food Protection · doi:10.4315/0362-028x.jfp-10-375 · Cited by 50
“between Treg-Thl, Th2, and Thl7 cells in an active state (23, 33), whereas the lack of Treg cells or the excessive production of effector T cells results in the development and exacerbation of IBD.”
BackgroundGoldberg, M. R., Nadiv, O., Luknar-Gabor, N., Agar, G., Beer, Y., & Katz, Y. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.01.004 · Cited by 46
Therapeutic efficacy of osthole against dinitrobenzene sulphonic acid induced-colitis in rats
Khairy, H., Saleh, H. M., Badr, A. M., & Marie, M.-A. S. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.01.104 · Cited by 46
Suyama, K., Sakai, D., & Watanabe, M. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.857164 · Cited by 52
“A small number of capillaries that penetrate only a fewmillimetres into the outermost AF (Sakai and Grad, 2015).”
BackgroundInfluentialSwitch receptor T3/28 improves long-term persistence and antitumor efficacy of CAR-T cells
Zhao, S., Wang, C., Lu, P., Lou, Y., Liu, H., Wang, T., Yang, S., Bao, Z., Han, L. G., Liang, X., et al. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-003176 · Cited by 52
IL-17A promotes the progression of Alzheimer’s disease in APP/PS1 mice
Cao, M., Liu, J., Zhang, X., Wang, Y., Hou, Y., Song, Q., Cui, Y., Zhao, Y., & Wang, P. (2023) · Immunity & Ageing · doi:10.1186/s12979-023-00397-x · Cited by 54
“IL-17A can increase the immunoreactivity and release of inflammatory mediators [23].”
BackgroundCCAAT/Enhancer-binding protein β promotes pathogenesis of EAE
Simpson-Abelson, M. R., Hernández-Mir, G., Childs, E. E., Cruz, J. A., Poholek, A. C., Chattopadhyay, A., Gaffen, S. L., & McGeachy, M. J. (2017) · Cytokine · doi:10.1016/j.cyto.2017.01.005 · Cited by 56
Self-citationInterleukin-17 Family Cytokines in Metabolic Disorders and Cancer
Meehan, E. V., & Wang, K. (2022) · Genes · doi:10.3390/genes13091643 · Cited by 51
“The MAPK signaling pathway has been shown to involve the following transcription modifiers: extracellular signal-regulated kinase (ERK) 1 and 2 (ERK1/ERK2), c-jun N-terminal kinase (JNK), and p38 [2,10,16,71,74,75,80].”
BackgroundSilva, J. A. F., Ferrucci, D. L., Peroni, L. A., Abrahão, P. G. S., Salamene, A. F., Rossa, C., Carvalho, H. F., & Stach‐Machado, D. R. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22979 · Cited by 44
IL-17/miR-192/IL-17Rs Regulatory Feedback Loop Facilitates Multiple Myeloma Progression
Sun, Y., Pan, J., Mao, S., & Jin, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114647 · Cited by 45
“Through a distinct pathway depend on ACT1, IL-17RA activation leads to culminating in the activation of NF-kB [25], MAPK [26] and PI3K [27] pathways which are usually associated with tumorigenesis.”
BackgroundTNFα ‐ and IL ‐17A‐mediated S100 A 8 expression is regulated by p38 MAPK
Mose, M., Kang, Z., Raaby, L., Iversen, L., & Johansen, C. (2013) · Experimental Dermatology · doi:10.1111/exd.12187 · Cited by 46
Th17 response in patients with cervical cancer (Review)
Alves, J., Fernandes, T. A. A. D. M., de Ara�jo, J., Cobucci, R. N., Lanza, D. C. F., Bezerra, F., Andrade, V., & Fernandes, J. V. (2018) · Oncology Letters · doi:10.3892/ol.2018.9481 · Cited by 64
“Studies have shown that IL-17A and IL-17F are capable of inducing expression of proinflammatory genes, alone or in synergy with TNF α , IL-6, G-CSF, IL-1 β , CXCL1, CCL20 and matrix metalloproteases (93), promoting the activation of NF-κ B, MAPK and C/EBP cascades (94).”
Peters, B. M., Coleman, B. M., Willems, H. M. E., Barker, K. S., Aggor, F. E. Y., Cipolla, E., Verma, A. H., Bishu, S., Huppler, A. H., Bruno, V. M., et al. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiz649 · Cited by 44
“Among the shared genes were multiple IL-17 family cytokines (Il17a, Il17c, Il17f), as well as genes characteristic of a classic IL-17–dependent gene signature [27, 28], including cytokines (Il1b, Il6, Il22, Il23A), chemokines (Cxcl2, Cxcl3, Cxcl6, Ccl2, Ccr1), and antimicrobial peptides (S100a8, S100a9, Defb3) (Figure…”
BackgroundSelf-citationThe Kallikrein-Kinin System: A Novel Mediator of IL-17-Driven Anti-Candida Immunity in the Kidney
Ramani, K., Garg, A. V., Jawale, C. V., Conti, H. R., Whibley, N., Jackson, E. K., Shiva, S. S., Horne, W., Kolls, J. K., Gaffen, S. L., et al. (2016) · PLOS Pathogens · doi:10.1371/journal.ppat.1005952 · Cited by 43
Self-citationPeláez‐García, A., Barderas, R., Batlle, R., Viñas-Castells, R., Bartolomé, R. A., Torres, S., Mendes, M. L., López-Lucendo, M. F., Mazzolini, R., Bonilla, F., et al. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m114.045328 · Cited by 43
“early differentiation of adipogenesis (32, 33).”
Heialy, S. A., Gaudet, M., Ramakrishnan, R. K., Mogas, A. K., Salameh, L. I. J., Mahboub, B. H., & Hamid, Q. A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01724 · Cited by 45
Effects of leukemia inhibitory factor on 3T3-L1 adipocytes
Hogan, J. C., & Stephens, J. M. (2005) · Journal of Endocrinology · doi:10.1677/joe.1.05980 · Cited by 43
“2002), and osteoblasts (Ruddy et al. 2004); thus, IL-6, an adipokine associated with obesity (Bastard et al.”
BackgroundMandour, M. A., Chen, S., & van de Sande, M. G. H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.618581 · Cited by 50
“The mice develop (histological) inflammation at the axial and peripheral entheses 1 week after curdlan induction followed by development of clinical enthesitis, sacroiliitis, peripheral arthritis and colitis and uveitis with increased serum levels of IFN-g, TNF-a, IL-6 and IL-17A.”
BackgroundInfluentialChen, C., Zhang, Q., Liu, S., Parajuli, K. R., Qu, Y., Mei, J., Chen, Z., Zhang, H., Khismatullin, D. B., & You, Z. (2015) · The Prostate · doi:10.1002/pros.22971 · Cited by 42
“GSK3B phosphorylates CAAT enhancer binding protein b (C/EBPb) and inhibits C/EBPb’s transcriptional function that is responsible for IL-17-induced gene expression [17,32].”
BackgroundKerkering, J., Muinjonov, B., Rosiewicz, K. S., Diecke, S., Biese, C., Schiweck, J., Chien, C., Zocholl, D., Conrad, T., Paul, F., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci164637 · Cited by 41
“Both IL-17A and TNF-α use TNFR-associated factor (TRAF) signaling pathways that synergize upon activation of inflammation-related genes via CCAAT/enhancer binding protein (C/EBP) (49).”
IL-17 reduces TNF-induced Rantes and VCAM-1 expression
Schnyder, B., Schnyder‐Candrian, S., Pansky, A., Schmitz, M. L., Heim, M. H., Ryffel, B., & Moser, R. (2005) · Cytokine · doi:10.1016/j.cyto.2005.02.012 · Cited by 42
IL-17 in Renal Immunity and Autoimmunity
Biswas, P. S. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1801042 · Cited by 42
“Additionally, C/EBP transcription factors act as transcriptional regulators of IL-17 signaling in target cells (13).”
BackgroundWu, Y., Konaté, M. M., Lu, J., Makhlouf, H. R., Chuaqui, R. F., Antony, S., Meitzler, J. L., Difilippantonio, M. J., Liu, H., Juhasz, A. N., et al. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1800469 · Cited by 41
“IL-17 is often described as an potentiator of inflammatory response because it promotes the production of cytokines such as IL-6, chemokines such as CCL5, and other inflammatory mediators and, as such, has been shown to synergize with other cytokines to increase inflammation (51, 52).”
BackgroundTNFα and IL-17 alkalinize airway surface liquid through CFTR and pendrin
Rehman, T., Thornell, I. M., Pezzulo, A. A., Thurman, A. L., Ibarra, G. S. R., Karp, P. H., Tan, P., Duffey, M. E., & Welsh, M. J. (2020) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00112.2020 · Cited by 38
“Although previous work has shown interactions between cytokine pathways, including TNF and IL-17 (14, 57, 74), and multiple cytokines mediate inflammatory response in vivo, to our knowledge the effect of more than one cytokine has not been explored on electrolyte transport or pHASL.”
MethodSynergistic effects of vascular IL-17 and TNF$alpha; may promote coronary artery disease
Csiszár, A., & Ungvari, Z. I. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2004.03.009 · Cited by 41
Witowski, J., Książek, K., Warnecke, C., Kużlan-Pawlaczyk, M., Korybalska, K., Tayama, H., Wiśniewska-Elnur, J., Pawlaczyk, K., Trómińska, J., Bręborowicz, A., et al. (2007) · Kidney International · doi:10.1038/sj.ki.5002082 · Cited by 38
IL-23/IL-17 Biology and Therapeutic Considerations
Dong, C. (2008) · Journal of Immunotoxicology · doi:10.1080/15476910801897953 · Cited by 38
“Recently, the downstream targets of IL-17 have been systematically analyzed by microarray analysis (Ruddy et al., 2004; Park et al., 2005).”
BackgroundLiu, A. C., Lee, M. W., McManus, B. M., & Choy, J. C. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102527 · Cited by 36
“Increased eNOS enzymatic activity in this setting is due to a TNF-a–mediated increase in the production of the eNOS cofactor tetrahydrabiopterin.”
BackgroundInfluentialA Multiomics Approach to Identify Genes Associated with Childhood Asthma Risk and Morbidity
Forno, E., Wang, T., Yan, Q., Brehm, J., Acosta-Perez, E., Colon-Semidey, A., Alvarez, M., Boutaoui, N., Cloutier, M. M., Alcorn, J. F., et al. (2017) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2017-0002oc · Cited by 31
Pappu, B. P., Angkasekwinai, P., & Dong, C. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.12.003 · Cited by 38
“Moreover, IL-17 also synergizes with TNF-α in inflammatory regulation (Ruddy et al., 2004).”
BackgroundThe Role of IL-17 in the Pathogenesis of Oral Squamous Cell Carcinoma
Ladjevac, N., Milovanović, M., Jevtović, A., Arsenijević, D., Stojanović, B., Stojanovic, M. D., Stojanović, B., Arsenijević, N., Arsenijević, A., & Milovanović, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24129874 · Cited by 39
“The IKK then phosphorylates the IκB subunit of the NF-κB:IκB complex and marks it for proteasomal degradation, exposing thus a nuclear localization signal on NF-κB, and allowing the rapid nuclear translocation and consequent inflammatory gene transcription [76].”
BackgroundInfluential
Metadata
- Authors
- Ruddy, M. J., Wong, G. C., Liu, X. K., Yamamoto, H., Kasayama, S., Kirkwood, K. L., & Gaffen, S. L.
- Affiliations
- University at Buffalo, State University of New York (US)
- The University of Osaka (JP)
- Corresponding author
- Gaffen, Sarah L.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2004-01
- Volume
- 279
- Issue
- 4
- Pages
- 2559-2567
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2087851913
- Cited by
- 364
- References
- 54
- Citations by year
- 2026: 6 · 2025: 13 · 2024: 15 · 2023: 10 · 2022: 20 · 2021: 24 · 2020: 14 · 2019: 15 · 2018: 19 · 2017: 21 · 2016: 14 · 2015: 20 · 2014: 22 · 2013: 13 · 2012: 18
- FWCI
- 6.24
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6134 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (AI49329, AI 07614, T32AI007614)
- National Institute of Dental and Craniofacial Research (DE14460, R03DE014460)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Keywords
- IL-17, TNF-α, C/EBP family, C/EBPδ, C/EBPβ, cytokine synergy, NF-κB, IL-6 promoter, transcriptional regulation
- MeSH terms
- Animals, Cell Line, Drug Synergism, Osteoblasts, Tumor Necrosis Factor-alpha, Signal Transduction, Transcriptional Activation, Interleukin-6, Interleukin-17, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.